Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:22 AM
Ignite Modification Date:
2025-12-25 @ 3:22 AM
NCT ID:
NCT06905405
Eligibility Criteria:
Inclusion Criteria:
* Male or female \> 18yrs of age.
* Symptoms of dysponea on exertion.
* NTproBNP \>400 ng/L in sinus rhythm (SR).
* Baseline TTE demonstrating a dilated LA (LA\>34 ml/m2), but that otherwise does not meet the current criteria for the diagnosis of HFpEF or HFrEF (preserved LV systolic function, Normal E/e', no evidence of LVH, Estimated PAP \< 35mmhg).
Exclusion Criteria:
* Inability to give informed consent. History of HFrEF
* contraindications to SGLT2 inhibitor (a history of type 1 diabetes mellitus, ketoacidosis, allergy to SGLT2 inhibitors, planned or current use of SGLT2 inhibitors or active genital infection).
* Atrial Fibrillation.
* Current history of anginal chest pain
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06905405
Study Brief:
Protocol Section:
NCT06905405